Homepage Insights News & Events News

Loyens & Loeff advised Orange Pearl International on the disposal of BioClin to Trimb Healthcare

Work highlight
10-12-2018
Loyens & Loeff advised Orange Pearl International B.V., a Dutch-based holding- and financial company on the disposal of BioClin B.V., a Netherlands-based healthcare company, to Trimb Healthcare AB, a Swedish-based OTC and consumer healthcare company.
Linkedin icon Twiter icon Mail icon
Sectors & Markets
Life Sciences & Healthcare
Expertises
Corporate / M&A
Linkedin icon Twiter icon Mail icon
Branding icon

Contact us

Gerda de Jong
Gerda de Jong
Senior Associate
Attorney at Law
Amsterdam
Louis Lutz
Louis Lutz
Partner
Tax Adviser
Amsterdam
Return to previous slide
Go to next slide
Other recent news
  • Sever Life Sciences agrees on the sale of the Nordic Group B.V. to Alfasigma
    14-08-2026
    Sever Life Sciences agrees on the sale of the Nordic Group B.V. to Alfasigma
    Our Corporate M&A and Tax teams advised Sever Life Sciences on its disposal of Nordic Group B.V., a European specialty pharmaceutical platform to Alfasigma.
    Work highlight
  • Introduction of a new Swiss Transparency Register
    10-08-2026
    Introduction of a new Swiss Transparency Register
    Switzerland's new Legal Entities Transparency Act (LETA) introduces a central register of beneficial owners, imposing new reporting and compliance obligations on companies.
    News
  • Loyens & Loeff advised PROM12 on the acquisition of Metrics Holding AG
    04-08-2026
    Loyens & Loeff advised PROM12 on the acquisition of Metrics Holding AG
    PROM12 expands its technology investment portfolio with the acquisition of Metrics Holding AG.  
    Work highlight
Logo Loyens & Loeff
Linkedin icon
Netherlands Belgium Luxembourg Switzerland
Legal & Privacy